US$ 22.21
diarrhea on a glp 1 can cause Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Adverse effects of GLP-1 class
Description
But wait, there was a twist
Retrieved March 10, 2026, from 6 Williams, E., Rudowitz, R., & Bell, C

GLP-1 signaling has been shown to inhibit activation of the NLRP3 inflammasome, a key driver of innate immune-mediated inflammation, and to enhance Treg activity, suggesting a broader role in restoring immune tolerance [26,27]

But with innovation come unpredictable variables
Also, it will have an impact on the broader ecosystem of healthcare services, potentially changing your patients population characteristics and their journey
For a peptide-based therapy , that track record is exceptional
